1. 516 THE CHARACTERIZATION OF DYSPLASIA IN BARRETT'S ESOPHAGUS—A PROSPECTIVE NATIONWIDE REGISTRY FROM THE RIBBON NETWORK. (14th September 2020) Authors: O Byrne, L; O' Brien, M; Muldoon, C; Ryan, C; Buckley, M; Murphy, T; Reynolds, R; Patchett, S; Kay, E; Azam, H; Robb, W; Arumugasamy, M; Mc Mathuna, P; Leyden, J; Gargan, S; Doherty, G; Sheahan, K; Collins, C; O Sullivan, J; Donohoe, C Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Leptin and adiponectin receptor expression in oesophageal cancer. Issue 6 (24th March 2014) Authors: Howard, J M; Cathcart, M C; Healy, L; Beddy, P; Muldoon, C; Pidgeon, G P; Reynolds, J V Journal: British journal of surgery Issue: Volume 101:Issue 6(2014:Jun.) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P095 Association between tissue oncostatin M expression and infliximab response in corticosteroid refractory acute severe ulcerative colitis. (25th January 2019) Authors: O'Connell, J; McDonagh, P; Clarke, N; Buckley, A; Dunne, C; Hartery, K; Larkin, J; MacCarthy, F; McCormack, P; McKiernan, S; Mehigan, B; Muldoon, C; Ryan, C; O'Sullivan, J; Kevans, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P223 Degree of Histological Activity is not Associated with Vedolizumab Therapy Outcome in Ulcerative Colitis. (27th May 2021) Authors: Doherty, J; Brennan, S; Dinneen, K; Muldoon, C; Mc Kiernan, S; Dunne, C; Mac Carthy, F; Hartery, K; Ciara, R; Kevans, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junction. Issue 2 (23rd December 2013) Authors: Lahiff, C; Schilling, C; Cathcart, M-C; Mulligan, N; Doran, P; Muldoon, C; Murray, D; Pidgeon, G P; Reynolds, J V; MacMathuna, P Journal: British journal of surgery Issue: Volume 101:Issue 2(2014:Feb.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PWE-018 Superiority of actual compared with close (<1 mm) circumferential resection margin involvement in the pathological staging of oesophageal and junctional cancer. (28th May 2012) Authors: O'Farrell, N J; Donohoe, C L; Costelloe, J M; Muldoon, C; Ravi, N; Reynolds, J V Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Value of CT–PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma. Issue 13 (28th October 2014) Authors: Elliott, J A; O'Farrell, N J; King, S; Halpenny, D; Malik, V; Muldoon, C; Johnston, C; Reynolds, J V Journal: British journal of surgery Issue: Volume 101:Issue 13(2014) Page Start: 1702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗